Beam Therapeutics Inc. (BEAM) Shareholders’ equity 2019–2025
Beam Therapeutics Inc. (BEAM) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.2BFY2025 · since FY2019: -$201.1M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +68.8% |
| FY2024 | $733.5M | -25.2% |
| FY2023 | $981.3M | +33.8% |
| FY2022 | $733.5M | -11.3% |
| FY2021 | $826.7M | +236.7% |
| FY2020 | $245.6M | +222.1% |
| FY2019 | -$201.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice